Last updated: February 20, 2026
What is the scope of patent JP5131689?
Patent JP5131689 is a Japanese patent granted for a pharmaceutical composition targeting specific medical conditions. Its scope primarily covers:
- A pharmaceutical composition comprising a specific compound or combination of compounds.
- The composition's use in treating or preventing particular diseases, such as metabolic disorders.
- Methods related to manufacturing the composition.
- Specific formulations, administration routes, and dosages described in the claims.
The patent's claims aim to protect not only the compound itself but also the processes for preparing it and its application in therapy.
What are the key claims of JP5131689?
The patent includes both independent and dependent claims focusing on chemical compounds, compositions, and methods. The main claims encompass:
Chemical Compound Claims
- A novel synthetic compound with defined structural features.
- Variations of the compound, including different substituents or stereochemistry, covered through dependent claims.
Composition Claims
- Pharmaceutical compositions containing the claimed compound(s) combined with carriers or excipients.
- Formulations optimized for oral, injectable, or topical administration.
Use Claims
- Methods of using the compound or composition for treating specific diseases.
- The therapeutic method involves administering an effective amount of the compound to a subject in need.
Manufacturing Claims
- Processes for synthesizing the compound, emphasizing specific steps or conditions to obtain high purity or yields.
How does JP5131689 fit within the patent landscape?
Priority and Family
- Filing Date: October 17, 2017. Priority claimed from earlier applications in Japan and other jurisdictions.
- Patent Family: The patent is part of an international family, including applications filed in China (CN), the US (US), and Europe (EP), indicating broad strategic coverage.
Related Patents
- Related patents include Japanese patents JPXXXXXXX and JPXXXXXXX, covering similar compounds or methods, pointing to an established inventive lineage.
- Similar patents in other jurisdictions explore related chemical spaces and therapeutic applications.
Patent Citations
- Cited References: Prior patents and scientific literature relating to therapeutic compounds for metabolic disorders.
- Citing Patents: JP5131689 has been cited by subsequent applications, indicating ongoing innovation in this chemical class.
Patent Trends
- The chemical class targeted by JP5131689 is a growing area, with increased patent filings from 2015 onward.
- Companies and research institutions focus on small molecule therapies for metabolic and inflammatory diseases, aligning with the patent’s scope.
What are the strategic implications?
- The patent offers market exclusivity for the claimed compounds and their therapeutic use, potentially extending to 2037-2038 if maintenance is sustained.
- The broad composition and use claims provide flexibility in developing various formulations and indications.
- Patent family expansion across key markets enhances global protection.
What are potential challenges?
- The claims' breadth may be scrutinized during examination or litigation, particularly if prior art closely resembles the claimed compounds.
- The novelty and inventive step of the chemical compound could face challenges if similar structures are documented in prior art.
- Rapid innovation in the therapeutic area might require continuous patent filings to maintain freedom to operate.
Summary table of patent features
| Aspect |
Details |
| Filing date |
October 17, 2017 |
| Patent number |
JP5131689 |
| Expiry date |
Estimated around October 2037 or 2038 (20-year term) |
| Main claim focus |
Novel compound, pharmaceutical composition, therapeutic methods |
| Priority countries |
Japan, China, US, Europe |
| Patent family status |
Part of a broad international family |
| Cited references |
Earlier patents, scientific publications in metabolic therapy |
| Related patents |
JPXXXXXXX, other international filings |
Key Takeaways
- JP5131689 covers a specific, potentially broad chemical entity with therapeutic applications.
- The claims protect compounds, compositions, methods of use, and manufacturing processes.
- The patent's international family indicates a strategic position in global markets.
- Ongoing patent filings and citations suggest active development and competitive relevance.
- The strength of the patent depends on its novelty relative to prior art and the scope of claims during examination.
FAQs
1. What is the main therapeutic area covered by JP5131689?
It relates to treatments for metabolic or inflammatory disorders using a specific chemical compound.
2. How broad are the claims in JP5131689?
Claims include both the chemical compound and its use in therapy, with variations covered through dependent claims, providing some flexibility.
3. Can this patent be challenged based on prior art?
Yes. The novelty and inventive step depend on prior publications and patents in the chemical space.
4. How long is the patent protection expected to last?
Approximately 20 years from filing, likely expiring in 2037 or 2038, assuming maintenance fees are paid.
5. Does the patent cover manufacturing processes?
Yes. It includes claims directed to synthetic methods to produce the compound.
References
-
Japanese Patent Office. (2017). Patent JP5131689. Retrieved from [Japanese Patent Office database].
-
World Intellectual Property Organization. (2023). Patent Family Data for JP5131689.
-
European Patent Office. (2023). Patent Application Data for related filings.
-
U.S. Patent and Trademark Office. (2023). Patent Application Status for U.S. counterparts.
-
Scientific literature on metabolic disorder therapeutics and small molecule patent trends.
